[go: up one dir, main page]

FI20040813A7 - Proteins that stabilize hydrophobic molecules - Google Patents

Proteins that stabilize hydrophobic molecules Download PDF

Info

Publication number
FI20040813A7
FI20040813A7 FI20040813A FI20040813A FI20040813A7 FI 20040813 A7 FI20040813 A7 FI 20040813A7 FI 20040813 A FI20040813 A FI 20040813A FI 20040813 A FI20040813 A FI 20040813A FI 20040813 A7 FI20040813 A7 FI 20040813A7
Authority
FI
Finland
Prior art keywords
proteins
substances
hydrophobic molecules
nanofilms
invention describes
Prior art date
Application number
FI20040813A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI20040813L (en
FI20040813A0 (en
Inventor
Tony Wahlroos
Petri Susi
Mauri Mäkelä
Timo Kalevi Korpela
Fusao Tomita
Original Assignee
Timo Kalevi Korpela
Tony Wahlroos
Petri Susi
Maekelae Mauri
Fusao Tomita
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Timo Kalevi Korpela, Tony Wahlroos, Petri Susi, Maekelae Mauri, Fusao Tomita filed Critical Timo Kalevi Korpela
Priority to FI20040813A priority Critical patent/FI20040813L/en
Publication of FI20040813A0 publication Critical patent/FI20040813A0/en
Priority to PCT/FI2005/000277 priority patent/WO2005121171A1/en
Publication of FI20040813A7 publication Critical patent/FI20040813A7/en
Publication of FI20040813L publication Critical patent/FI20040813L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • C11B5/0007—Organic substances
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • C11B5/0021—Preserving by using additives, e.g. anti-oxidants containing oxygen
    • C11B5/0028—Carboxylic acids; Their derivates
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • C11B5/0085—Substances of natural origin of unknown constitution, f.i. plant extracts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/86—Products or compounds obtained by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Edible Oils And Fats (AREA)

Abstract

Keksintö kuvaa polypeptidinanofilmejä ja hydrofobisia ja hydrofiilisiä faaseja. Keksinnössä kuvataan spesifisten proteiinimolekyylien kykyä muodostaa ohuita kerroksia suorilla tai kaartuvilla vesipakoisilla pinnoilla; nämä kerrokset estävät tehokkaasti aineiden liikkumisen nanofilmien välillä. Keksintöä voidaan käyttää suojelemaan rasvoja, öljyjä ja niihin suspentoituja aineita hapen ja kaasumaisten aineiden vaikutuksilta.The invention describes polypeptide nanofilms and hydrophobic and hydrophilic phases. The invention describes the ability of specific protein molecules to form thin layers on straight or curved hydrophobic surfaces; these layers effectively prevent the movement of substances between the nanofilms. The invention can be used to protect fats, oils and substances suspended in them from the effects of oxygen and gaseous substances.

FI20040813A 2004-06-14 2004-06-14 Proteins that stabilize hydrophobic molecules FI20040813L (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20040813A FI20040813L (en) 2004-06-14 2004-06-14 Proteins that stabilize hydrophobic molecules
PCT/FI2005/000277 WO2005121171A1 (en) 2004-06-14 2005-06-14 Proteins stabilizing hydrophobic molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20040813A FI20040813L (en) 2004-06-14 2004-06-14 Proteins that stabilize hydrophobic molecules

Publications (3)

Publication Number Publication Date
FI20040813A0 FI20040813A0 (en) 2004-06-14
FI20040813A7 true FI20040813A7 (en) 2005-12-15
FI20040813L FI20040813L (en) 2005-12-15

Family

ID=32524488

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20040813A FI20040813L (en) 2004-06-14 2004-06-14 Proteins that stabilize hydrophobic molecules

Country Status (2)

Country Link
FI (1) FI20040813L (en)
WO (1) WO2005121171A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012106751A1 (en) * 2011-02-07 2012-08-16 Commonwealth Scientific And Industrial Research Organisation Artificial oil bodies
CN111888525B (en) * 2020-07-30 2021-08-10 齐鲁工业大学 High-potential hydrophobic polypeptide monolayer film and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2291274C (en) * 1997-05-27 2006-05-16 Sembiosys Genetics Inc. Uses of oil bodies
BR0015693A (en) * 1999-11-18 2002-07-16 Nestle Sa Recombinant cocoa oleosins and their use as flavoring and emulsifying agents
JP3619137B2 (en) * 2000-09-28 2005-02-09 日本水産株式会社 Oil body-like or shell-shaped nanocapsules and method for producing the same

Also Published As

Publication number Publication date
FI20040813L (en) 2005-12-15
WO2005121171A1 (en) 2005-12-22
FI20040813A0 (en) 2004-06-14

Similar Documents

Publication Publication Date Title
EA201000424A1 (en) ANTIBODIES TO IL-23
WO2008121615A3 (en) Antibody formulation
CO6180445A2 (en) ANTI NOTCH3 AGONIST ANTIBODIES AND THEIR USE IN THE TREATMENT OF DISEASES RELATED TO THE NOTCH3 GENE
CO6180433A2 (en) LINGO LINK MOLECULES AND PHARMACEUTICAL USE OF THE SAME
HUP0402162A2 (en) Specific binding agents of human angiopoietin-2
EA201170312A1 (en) SELECTIVE ANTIBODIES TO HEPCIDINE-25 AND THEIR APPLICATION
DE602005012555D1 (en) Artificial protein for the absolute quantification of proteins and uses thereof
EA202190999A1 (en) COMPOSITIONS BASED ON POLYPEPTIDES STABILIZED WITH DISULPHIDE BONDING AND METHODS OF APPLICATION
EP4491268A3 (en) Fc binding proteins with cysteine in the c-terminal helical region
MX2010002769A (en) Recombinant preparation of selected bromelain fractions.
MX2021012047A (en) Serpin fusion polypeptides and methods of use thereof.
ATE472998T1 (en) CATIONIC LIPOSOMAL PREPARATIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
ATE463512T1 (en) IDENTIFICATION AND CHARACTERIZATION OF FUNCTION-BLOCKING ANTI-ED-B-FIBRONECTIN ANTIBODIES
PH12022552935A1 (en) Stabilized coronavirus spike protein fusion proteins
PL4196797T3 (en) Methods of identifying the presence and/or concentration and/or amount of proteins or proteomes
DE602006018592D1 (en) TNF-ALHPA-BINDING POLYPEPTIDE, APPLICATIONS THEREOF AND METHOD WHERE THIS IS USED
WO2007100874A3 (en) Compositions containing peptides with non-natural amino acids and methods of use
YU75600A (en) Application of polypeptides of e
ATE497009T1 (en) 3-NON-TRANSLATED HYBRID AREAS SUITABLE FOR EFFICIENT PROTEIN EXPRESSION IN MAMMAL CELLS
FI20040813A7 (en) Proteins that stabilize hydrophobic molecules
DK1589834T3 (en) Enteral composition for the prevention and / or treatment of sepsis
DE602004019701D1 (en) Peptides which bind to Apo2L (Trail) receptors and uses thereof
CL2008003614A1 (en) C7 replication deficient simian adenovirus vector comprising the cs protein of p. falciparum or a fragment thereof; composition containing it in combination with a malaria antigen and a co-adjuvant; Useful in the treatment or prophylaxis of malaria.
EA200971092A1 (en) VEGF-D MUTANTS AND THEIR APPLICATION
AR068038A1 (en) POLYPEPTIDES OF THE MODIFIED GROWTH HORMONE

Legal Events

Date Code Title Description
FD Application lapsed